Background: Cow's milk protein (CMP)-specific IgG4 responses and the efficacy of oral desensitization in infants with cow's milk allergy (CMA) warrant more clarification.
Objective: To explore whether CMP-specific IgG4 responses develop during infancy and whether regular CM exposure is efficacious for inducing a CMP-specific IgG4 response accompanying CM desensitization in 7- to 12-month-old infants.
Methods: CM-specific IgE and CMP (α-lactalbumin, β-lactoglobulin, and casein)-specific IgG4 levels were measured in 262 CM-sensitized children. Of these, 31 infants 7 to 12 months old with challenge-proved CMA were randomly assigned to oral desensitization or an elimination diet and evaluated 6 months later.
Results: CMP-specific IgG4 levels in 7- to 12-month-old infants were higher than in those younger than 6 months but comparable to those in children older than 12 months. CMP-specific IgG4 levels in 7- to 12-month-old infants with CMA were significantly lower than in those without CMA. Fourteen of 16 patients receiving oral desensitization could accept daily doses of 200 mL of CM, whereas all but 3 dropout patients receiving the elimination diet still showed allergic symptoms at the follow-up food challenge. In patients who became desensitized, CM-specific IgE levels were lower than at baseline, whereas CMP-specific IgG4 levels were significantly increased. In patients receiving the elimination diet, CM-specific IgE and CMP-specific IgG4 levels remained unchanged.
Conclusion: CMP-specific IgG4 responses did not develop sufficiently in 7- to 12-month-old infants with CMA. Oral desensitization in 7- to 12-month-old infants with CMA was associated with the upregulation of CMP-specific IgG4 responses accompanying the alleviation of CMA symptoms.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.anai.2013.09.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Markers of gut mucosal inflammation and cow's milk specific immunoglobulins in non-IgE cow's milk allergy.
Clin Transl Allergy
March 2014
Children's Hospital, Division of Pediatric Gastroenterology, Helsinki University Central Hospital, PO BOX 281, FIN-00029 HUS, Helsinki, Finland.
Background: Allergy to cow's milk protein (CMP) may cause gastrointestinal (GI) symptoms in the absence of CMP specific IgE. The immunological mechanisms involved in such disease are not fully understood. Therefore we examined markers of gut mucosal inflammation and the immunoglobulin profiles in children with Gl symptoms suspected of cow's milk protein allergy (CMPA).
View Article and Find Full Text PDFIncreased cow's milk protein-specific IgG4 levels after oral desensitization in 7- to 12-month-old infants.
Ann Allergy Asthma Immunol
December 2013
Department of Pediatrics, College of Medicine, Chungbuk National University, Cheongju, Korea.
Background: Cow's milk protein (CMP)-specific IgG4 responses and the efficacy of oral desensitization in infants with cow's milk allergy (CMA) warrant more clarification.
Objective: To explore whether CMP-specific IgG4 responses develop during infancy and whether regular CM exposure is efficacious for inducing a CMP-specific IgG4 response accompanying CM desensitization in 7- to 12-month-old infants.
Methods: CM-specific IgE and CMP (α-lactalbumin, β-lactoglobulin, and casein)-specific IgG4 levels were measured in 262 CM-sensitized children.
In vivo evidence of cross-reactivity between cow's milk and soybean proteins in a mouse model of food allergy.
Int Arch Allergy Immunol
September 2012
Laboratorio de Investigaciones del Sistema Inmune, Facultad de Ciencias Exactas, Universidad de La Plata, La Plata, Argentina.
Background: Cow's milk allergy (CMA) is an important problem worldwide and the development of an in vivo system to study new immunotherapeutic strategies is of interest. Intolerance to soybean formula has been described in CMA patients, but it is not fully understood. In this work, we used a food allergy model in BALB/c mice to study the cross-reactivity between cow's milk protein (CMP) and soy proteins (SP).
View Article and Find Full Text PDFA specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy.
Allergy
March 2009
Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
Background: It has been suggested that human breast milk oligosaccharides play a role in the development of the immune system in infants, and may consequently inhibit the onset of allergy. A specific prebiotic mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides (GOS/FOS) has been shown to reduce the incidence of atopic dermatitis (AD) at 6 months of age in infants at risk for allergy.
Aim Of The Study: This study was aimed to analyze the effect of GOS/FOS on the immune response in these infants.
Maintenance of tolerance to cow's milk in atopic individuals is characterized by high levels of specific immunoglobulin G4.
Clin Exp Allergy
July 2007
Department of Dermatology/Allergology, University Medical Center, Utrecht, The Netherlands.
Background: The central role of specific IgE in cow's milk allergy (CMA) is well documented. However, less is known about the function of other immunoglobulin isotypes in allergy and tolerance to cow's milk proteins (CMPs).
Objective: To determine differences in the antibody responses that are associated with allergy and tolerance to cow's milk in allergic, atopic and non-atopic individuals of different age groups.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!